Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions

Details for Australian Patent Application No. 2006328951 (hide)

Owner Novartis AG

Inventors Collingwood, Stephen Paul; Smith, Nicola

Agent Davies Collison Cave

Pub. Number AU-B-2006328951

PCT Pub. Number WO2007/071396

Priority 0526240.7 22.12.05 GB

Filing date 20 December 2006

Wipo publication date 28 June 2007

Acceptance publication date 11 November 2010

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/70 (2006.01) - Carbohydrates

A61P 11/12 (2006.01) Drugs for disorders of the respiratory system

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/071396 Priority application(s): WO2007/071396

11 November 2010 Application Accepted

  Published as AU-B-2006328951

17 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006328955-Pyrazine derivatives as epithelial sodium channel blocker

2006328950-Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers